This article is part of an extensive feature on the 2023 HAEi Regional Conference EMEA, published in Global Perspectives #2 2023

The Patient and Caregiver Track consisted of many exciting topics – click on a topic to know much more about what went on during the sessions:

To conclude the first evening of the HAEi EMEA Regional Conference, another double act was welcomed to the stage, this time Fiona Wardman, HAEi’s Executive Vice President Global Advocacy and Chief Diversity Officer, and Jørn Schultz-Boysen, Executive Vice President Global Operations and Chief Compliance Officer.

Welcoming everyone back from the movement break, Fiona introduced the session. She and Jørn will present some services and programs to help MOs, patients, and caregivers improve their quality of life and win access and reimbursement for life-saving and life-giving HAE medicines.

Jørn told the audience about the travel partner, HAE Companion. Although it started as a tool to make travel easier, it also helps with emergency department visits, explained Jørn, as it can store emergency cards in 80 languages and put every ACARE center on earth at your fingertips, even guiding you straight to the nearest to you. Jørn urged everyone present to download HAE Companion. It’s free, available via Google Play and the App Store, and accessible in 84 countries.

HAE TrackR was the second resource shared. Based on an easy-to-use electronic diary, HAE TrackR helps people take control of their HAE by recording treatments, attacks, and disease burden and giving them sole ownership of all the data they enter. Jørn remarked that Prof. Maurer had already mentioned the importance of using a diary app to personalize treatment for every individual on their terms. Currently available in 34 languages, HAE TrackR can be accessed from any internet-enabled device. Later in the meeting, Jørn told the audience there had been 62 downloads of HAE TrackR in the audience and encouraged everyone to get it and see the great benefit.

Fiona took on the next tech, HAEi Connect, addressing all the MOs who deal with members’ personal data. With security at its heart, HAEi Connect complies with the EU General Data Protection Regulation (GDPR), encrypting data and using two-factor authentication. She told the audience that, far more than just a data repository, HAEi Connect is a powerful tool to communicate with members.

Next up was the emergency card, which Fiona recommended to the audience as a quick and effective way to let your healthcare professional know you have a diagnosis of HAE on arrival at a hospital or care center. Containing clear and straightforward information about HAE and treatment required during an attack in a wide range of languages, “it could be a lifesaver,” Fiona concluded. Complementing this are the emergency posters, which can be hung in hospitals and emergency rooms to educate non-specialist physicians about HAE.

Finally, the Understanding HAE patient guide was in the spotlight. Fiona informed the audience that this stemmed from MO requests and was developed with the strong support of the US Hereditary Angioedema Association (US HAEA) to describe all things HAE and HAEi comprehensively. Sections include traveling and triggers, diagnosis and treatment, HAE and children, pregnancy, and more.

Rounding things off for the evening, attendees were given their first chance to sample the fine Bavarian hospitality alluded to by Prof. Maurer a short while earlier.

Fiona started the session by getting the audience energized for the day ahead. She then provided some statistics to set the scene of HAE across the EMEA region before inviting each of the Regional Patient Advisors to give an update on their region.

Some of the facts Fiona shared were:

  • There are 8 billion people in the world
  • Between 7-8,000 different rare diseases
  • On average, one in 26.6 people has a rare disease
  • There are more than 100 countries and 2.2 billion people living in the EMEA region
  • There are approximately 74,000 people with HAE in EMEA

Fiona then told the audience that according to the World Economic Forum, the top three challenges for rare diseases are lack of priority, limited capacity and capability for diagnostics, and limited accessibility to treatments. Challenges that many people in this room know only too well, she said.

Following her introductory remarks, Fiona invited the five EMEA RPAs onto the stage: Michal Rutkowski, Patricia Karani, Natasa Angjeleska, Maria Ferron, and Jørn Schultz-Boysen.

Benelux, Central Eastern Europe, and Middle East

Michal Rutkowski explained that Benelux covers Belgium, the Netherlands, and Luxembourg. All three are in the European Union (EU), easing access and reimbursement for modern treatments. Identifying patients and healthcare professionals in Luxembourg has been a priority. In Central Eastern Europe, a vast and diverse region, some countries are in the EU. The situation is more challenging outside the EU, with perhaps one modern treatment or none at all. Access to clinical trials can also be a problem. This means strong local Member Organizations are vital, and this is a crucial priority for Michal. Finally, Michal described the general situation across the Middle East. Although there are 12,300 potential HAE patients, only 10% have been diagnosed. Across the region, there is a great deal of difference between countries. In the six countries of the Gulf Cooperation Council (GCC), medical insurance means reimbursement of modern therapies is possible for citizens, whereas non-citizens (non-nationals of GCC countries) can face problems. The situation is more challenging in countries outside the GCC, such as Egypt, Lebanon, Syria, Jordan, Iran, Iraq and Yemen. Michal is heavily involved in advocacy work in these countries.

Nordics, Germany, Austria, Switzerland, and Israel

Jørn Schultz-Boysen told the audience that his region stretched from Greenland in the far north to Israel in the south, as well as taking on the German-speaking countries of Germany, Austria, and Switzerland and the Nordic countries of Finland, Sweden, Norway, Denmark, Iceland and the Faroes. Jørn described his region as fortunate, being well served with treatment options. For Jørn, the key word across the region is ‘maintain.’ He works hard with MOs to ensure that access is preserved. Increasing medicine prices in some countries lead policymakers to consider restrictions, so continuing advocacy work is vital. Additionally, Jørn remarked that maintaining the support and commitment of patients and caregivers to their local organization is vital. He ended with a message for all those present to support their local HAE organization, participate in meetings, complete surveys, and encourage young people to join activities.

South Eastern Europe

Fiona then turned to Natasa Angjeleska. Natasa said her region of 147 million people showed many of the different challenges facing HAE advocacy. She made clear that for the countries in the EU, there is reason for optimism around access and reimbursement, but other countries in the region fared less well. She highlighted that some countries, such as Bosnia and Herzegovina, Kosovo, and Albania, have no medicines access; patients rely on donations or clinical trials. It is here that the regional approach comes into its own, she said, as countries can assist and support each other. There are also reasons for positivity. In North Macedonia, the first confirmed diagnosis has occurred, which is core to Natasa’s focus on ensuring patients are identified and not left alone and in pain. She agreed with Professor Maurer’s rallying cry of No Patient Left Behind. She never takes no for an answer, preferring to see each no as an opportunity to fight harder.

Mediterranean, North Africa, and British Isles

Next up was Maria Ferron and her region, which straddles Europe and Africa. Even within EU countries, Maria mentioned frustrations, such as needing individual areas within Italy and Spain to approve medication reimbursement. There are some reimbursed medicines in Algeria and Libya, but in Morocco, reimbursement has yet to be accepted. Her ongoing work is heavily focused on supporting new Member Organizations and working to locate more patients.

Sub Sahara Africa

Patricia Karani spoke next. Her region is significantly populated, with around 1.2 billion people and 40,000 potential HAE patients. Unfortunately, she said, in most of Africa, Governments focus on common diseases like malaria, so money is not set aside for rare diseases. She focused on positive steps. Patients are being trained to speak up and become advocates. More healthcare professionals are being trained to identify and diagnose HAE, which has been a five-year journey. Some modern treatment has been acquired. Patricia made clear her focus is to raise awareness amongst healthcare professionals to give patients hope of a diagnosis. She said, “It’s one step at a time.”

Fiona added to Patricia’s presentation with an update from South Africa. Fiona has been assisting the Member Organization to locate more patients. The tools and resources HAEi offers are critical to this, allowing the MO to grow by securing funding.

Fiona then invited all RPAs to take part in a panel discussion – click to read more about each topic:

Michal raised communication difficulties as a challenge. Even within Belgium, the Flemish and French-speaking parts made setting up a single, strong advocacy organization more difficult. In the Middle East, around 90% of patients are undiagnosed. Finally, Michal mentioned the challenge of attracting young people into advocacy.

Natasa described the complicated administrative structure of countries in her region, such as Bosnia and Herzegovina, where politics adds challenges. However, the priority across her region is to get access to preventive treatment and ensure all twelve countries have a Member Organization.

Maria agreed with the issues raised. Additionally, finding people prepared to take on patient advocacy is an issue due to the work involved. Spreading the load is crucial. She encouraged people to get involved with their local organizations. Even a little extra help will be hugely appreciated.

For Jørn, we must not allow what we have to be lost. For him, it’s a right for patients to be treated and have the quality of life we know they can have. Staying united as a Member Organization is so important.

Patricia spoke of stigmatization. With a disease that doctors do not know well, there is still the potential to be labeled as ‘cursed.’ This can lead to patients being lost or not wanting a diagnosis. She fights this stigma by making people aware of the global community. People can then see it’s not just them as individuals; they are not alone and are accepted.

Patricia said that C4 testing is available to assist with diagnosis; however, C1 testing requires going outside the region, such as to Germany or South Africa. In countries in the region that are war-torn, diagnosis often relies only on family questions and looking at the history.

According to Michal, it is disappointing that C1, C4, and genetic testing are not more widely available. In the countries of his region, there is a lot of variation. In Benelux and the other EU countries, laboratory and genetic testing is available. Outside this, the picture is more mixed, with some even needing to send samples outside the country for testing.

In Natasa’s region, it was also not uncommon for patients to have to travel to neighboring countries for diagnosis, adding to costs. Having other family members with the disease can be helpful as it helps with symptom recognition. However, she told her own story of seeking a diagnosis for her adopted child, which shows how hard diagnosis can be when there is little knowledge of the family history.

Maria echoed the problems of needing to travel abroad for blood tests in some countries, which can add time, stress, and costs.

Fiona introduced this question, commenting that an educated patient is an empowered patient.

The group agreed that industry needs to hear the patient voice, to help them directly develop and meet the needs of people.

The theme of telling your story to the media was returned to as a potent way for the patient voice to be heard.

Jørn spoke about the uniqueness of each patient experience and that; “No one knows HAE better than we do as patients and caregivers; we should be the ones that speak and have the privilege to be heard.“

Patricia told the audience that she was scared of speaking about her HAE, but when she started, it gave her strength, and she began to accept that it was OK to have HAE.

Moving onto the next question, Patricia stressed the importance of advocacy in educating healthcare professionals.

Jørn felt that although advocacy is hard work, it has an enormous impact. Maintaining access will be entirely a result of the advocacy work across his region.

Natasa spoke powerfully about how advocacy was ‘fighting for the right to live’ and that sharing our stories can motivate and empower others to do the same.
Educating yourself about treatments and research will give you the ability to speak with those who make decisions on your behalf.

The power of media advocacy was raised. One African patient telling his story on radio and TV led to increased access to treatments in a short period of time. Maria encouraged everyone to share their experience.

Fiona spoke of how receptive HAEi is to anyone with ideas about advocacy in their region or country. “Speak to your RPA,” she told the audience. ‘They can share knowledge of where others may have done something similar or help you in any way.’

On the final question, Fiona remarked that data is the summary of many individual stories, making it so powerful.

Jørn commented that much work is being done in his region to generate data, which is important to create stronger arguments when we speak to policymakers.

Patricia recalled meeting a health minister who asked how many people with HAE there were, but at the time, the only people in the country were the four members of her family. The minister was dismissive of such small numbers, but the actual figure will be much higher than that, which makes data so important.

The group also agreed that data is how patients can better manage their condition; get a quicker diagnosis; find an effective treatment and get reimbursement.

The effectiveness of having your own data was also mentioned. The panel highly recommended HAE TrackR to collate your own data.

Fiona then turned to the audience with a question: What percentage of rare diseases have treatments? The options were: 67%, 47%, 27% or 7%. There wasn’t a clear consensus from the audience, but the answer was 7%, which Fiona said demonstrates how lucky HAE patients are to be part of that small percentage that does have treatment.

Before turning to messages of support from across all the Member Organizations within HAEi, Fiona stressed with a Dr. Zeus quote, “We are the ones we’ve been waiting for. You have the power to Take Action and improve things for yourself and for the HAE community where you live.“

And with that, the panel shared the Member Organization’s messages. You can read all these by clicking here to see the slides. Fiona thanked all the Member Organizations for their fantastic work and the RPAs for their efforts in support.

In conclusion, Fiona told the delegates that we have made much progress in raising awareness and access to modern treatment in the past few years. Even though many challenges remain, there is good reason for hope and optimism.

Jørn and Michal returned to the stage to discuss awareness raising. The first question posed was to Michal: Why is raising awareness important? Michal said it’s the basis of success, increasing enthusiasm and support, stimulating action, and generating local knowledge.

So, ‘where do you start with raising awareness?’ asked Jørn. ‘Talk to as many people as possible,’ said Michal.
He also encouraged people to look around them in the community; look at who is speaking and consider what they are saying. You can use social media as a really powerful tool, but use it to impact, not impress, people. He said to use it to show people who you are and what you stand for. Make as many connections as possible, both on and off social media.

Michal continued that awareness raising can also be turbo-charged by the tools and resources HAEi offers:

  • Use emergency cards and emergency posters to spread awareness. They are in a vast range of languages
  • Make use of resources for schools to educate when children start their studies
  • Create or update a website for your community using HAEi’s free templates and web hosting. Jørn showed new websites from HAE Scandinavia, HAE South Africa, HAE Turkey, HAE Kuwait and HAE Georgia
  • Share information materials. Your Member Organization will have hard copies and electronic versions available. Another example was an information film produced by HAE Switzerland
  • Attend meetings. These can be local, national, regional and global events, casual catch-ups, or formal leadership sessions. Jørn made clear that everyone can benefit from finding out the most up-to-date information, as knowledge is power
  • Encourage young people to become involved. The HAEi Youngsters Community is over 100 young people who share personal experiences and meet others. HAEi LEAP helps equip the advocates of tomorrow with skills and experience to raise awareness and advocate for HAE; it’s also great fun
  • Take courses on HAEi Advocacy Academy to learn more and brush up on skills like press release writing
  • Get involved with hae day :-). Everything you do helps bring us all together as one big family. The hae day :-) website has all you need to get ready for 16 May
  • Contact government officials to raise awareness. Writing and meeting local politicians regularly will keep HAE front of mind for people
  • Offer to tell your story to the media. Talking in public can be daunting, but it becomes easier once you’ve done it the first time, and the benefits are huge

Jørn encouraged people to be persistent when taking action and celebrate all successes, no matter how small. He commented, “Persistency will get you there, but consistency will keep you there.”

Finally, both speakers reiterated that they and their fellow RPAs have lots of experience raising awareness and are only too willing to help. Just ask!

Fiona and Tony led the audience through the path to success and how best to Take Action.

Tony explained what Take Action meant in practice for him. It means participating in patient-driven research. It means being involved with your Member Organization. But for the HAEi team, according to Tony, it means waking up every day thinking about how to help the HAE community.

“For us,” Tony said: “HAE is personal. We know what it’s like to suffer. We feel what you feel. And we take this emotion into our day-to-day work.”

Starting with research, Tony described the highly successful Heat Map survey as perfect for new Member Organizations or areas with little diagnosis. He described the situation in the Philippines, where doctors told him there were “no HAE patients.” After a Heat Map Survey, 28 pockets of swelling disorder symptoms were uncovered, and a previously unknown group of 14 HAE patients was found. Once pockets are identified, Member Organizations can go there and educate people so that diagnoses will follow. Similar surveys are now planned in Rwanda and Bangladesh.

Just one person’s actions can make a difference. Tony described the situation in Macedonia, where patients didn’t take no for an answer and worked hard to make things happen.

The State of Management of HAE is another fantastic resource, Tony told the audience. It provides an individual analysis of country circumstances to establish the needs of people with HAE. Tony remarked: “As we all know when this rare condition is not adequately treated, it qualifies as a catastrophic unmet medical need.” These studies are now due to be updated, so look out for your opportunity to be involved.

Tony then explained the Baseline Burden of Illness research. These are for countries where access to therapy is inadequate. “Testimonials will bring a tear to the eye, but only combined with the data that these studies produce will you get decisions made.” This research shows the true burden of living with HAE, such as the number of attacks experienced, days of work and school missed, and the impact on healthcare systems through emergency room visits and deaths. Research of this kind has recently taken place in India and Mexico, with a study ongoing in South Africa and plans for Colombia.

HAEi conducts a Pharmacoeconomic, Socioeconomic, and Quality of Life Assessment study. This is focused on countries where reimbursement may be lacking. Already complete for the Nordics, Australia, New Zealand, and the UK, with research just starting in Germany and Switzerland, these show governments that there is great value in these medicines because they reduce hospitalizations, emergency room visits and allow people to work and study more.

Finally, Tony said there are Shared Decision-Making Tools. These capture your preferences and assessment of HAE so that better decisions are made about your treatment when the data is shared with your doctor. This is a pilot in the United States right now but will go global in the near future.

“Our research will make a difference to your ability to Take Action,” Tony concluded his remarks before handing over to Fiona.

Fiona told the audience the path to success is: “Simply put, one of community involvement. It is critical. What goes on in your HAE community directly affects you.” She shared another powerful observation: “Luck is what happens when preparation meets opportunity.” She illustrated this by demonstrating her journey of co-founding HAE Australasia almost 13 years ago. She admits she had no idea what she was doing. But a combination of determination, commitment, patience, and the tools available from HAEi made it much easier to create a productive group.

“When people put their hand up and take action on advocacy, it’s up to all of us to support them,” she said. It can be scary and fun, but it never stops. And if it does stop, then things will quickly slip backward.

Referencing the pioneering work and spirit of Dr. William Osler (who was the first to describe the illness that became known as HAE), Fiona asked the audience to think if they are happy with the current situation for HAE, and, if things are good, not just to assume others will do the work to maintain this. Everybody needs to take part, doing what they can. Your fresh ideas and opinions are welcome. Just let your local patient group know you’d like to support them and what you can do (whether it’s an amount of time or a skill like accountancy or social media).

Fiona asked people to imagine their medication or care being taken away. Having something now is not a long-term guarantee. She concluded the session by saying: “Don’t be a spectator; become an active participant in making the world what you would like it to be. Always believe that you can make a difference because the smallest things you do can lead to the biggest change.”

Introduced to the stage by Michal Rutkowski, four brave and committed people with HAE took turns to tell their own stories in their own words.

Marijk Beekman-Kortekaas – Netherlands

“I’ve always looked at what I can do instead of what I can’t do.”

Speaking first, Marijk revealed she waited almost 30 years to get a diagnosis despite living in a rich country with an excellent healthcare system. One clue to this delay is that she is the only per-son in her family with HAE. The lack of a multidisciplinary approach also contributed, as many different specialists didn’t communicate with each other, meaning no one could agree that it was a single disease. In those 30 years, Marijk nearly died three times from throat attacks and under-went three unnecessary surgeries. She lost count of the hospital admissions, with her symptoms starting when she was just a baby. Over the years, she has been misdiagnosed many times, with illnesses including allergies, asthma, reflux disease, and Crohn’s disease, leading to a vast number of medicines which, of course, didn’t work.

Growing up, Marijk remembers missing out on life, never making birthdays, holidays, or parties. When puberty hit, her attack frequency and severity increased, eventually reaching one or two attacks a week. Hand and foot attacks after sports stopped her from playing tennis or running. Finishing her education was difficult, and work was impossible due to the constant need for sick leave. Despite all this, Marijk maintains a positive outlook; “I’ve always looked at what I can do instead of what I can’t do.”

Finally, her gastroenterologist conducted a colonoscopy during a swelling and told her he knew what was wrong with her.

Embarking on a quest to educate herself on her ‘new’ condition, Marijk got a referral to a leading HAE specialist in the Netherlands. Treatment was available but required hours of discussion in hospital. At this point, Marijk admits it was time for self-management, but she was scared.

Marijk recalls: “My specialist was so empowering. He trained me to administer for myself, and as a test, he let me put a needle in his vein. That was such a powerful moment. Putting a needle in the vein of your doctor, I knew I could handle living with the disease.”

Despite attacks and trying lots of treatment options, she is now getting periods of relief every month. To help others, she decided to become President of the Member Organization in the Net-herlands. She was nervous about traveling to an HAEi meeting in Frankfurt to get ideas and con-nections, but her Regional Patient Advocate welcomed and empowered her. She left the meeting a different person. She concluded by saying: “Together we can move mountains.”

Daniella Nhaguilunguana – Mozambique

With new knowledge from the conference, Daniella is excited to go home and work with her doctors.

The next to speak was Daniella from Mozambique. She, like Marjik, is the first patient in her family to have been diagnosed with HAE. She described Mozambique as a developing country on the south and eastern coast of Africa, which means diagnosis of HAE is “a little bit complicated.”

Daniella describes her first attack at the age of four. “Out of nowhere,” she says: “my lips started swelling so much that my mouth closed. Everybody looked at me like I was a piece of art in a museum before being rushed to hospital.”

Afterward, Daniella tells of many years of similar attacks. Every time she went to the hospital, they had no answers. At 14, a tongue swelling started to cut off her breathing. In what she and her family describe as a “miracle,” she started breathing again and got better. After a trip to South Africa for tests yielded no results, the doctors gave her the prognosis that she wouldn’t live long.

Things started to change for Daniella when she left Mozambique to study in India. After a severe attack put her in hospital in a medically induced coma, she met Dr Pratik Agarwal, who had some information about HAE. Blood samples were taken and sent away to Singapore for testing. A couple of months later, Daniella finally had a diagnosis. Daniella recalls: “I was so scared. I was alone in a country getting a very rare disease diagnosis. I stopped going to the hospital for a while, but after another attack, my doctor finally convinced me to get treatment.’ Daniella found relief with stanozolol, but it caused side effects. During attacks, FFP and tranexamic acid were used.

Her attacks continued, but Daniella was encouraged that her Indian doctors were willing to learn, but she was nervous about returning to Mozambique after her studies. She worried: ‘How am I going to explain to doctors this is not an allergy or some sort of curse, but a real disease?’ Her nervousness was helped when she contacted HAEi and met Patricia Karani (the RPA for Sub Sahara Africa). Patricia supported and connected her with a doctor in Mozambique who had information about the disease.

Although treatment options in Mozambique remain very limited, Daniella continues to live her life. Earlier this year, she traveled to a remote province of her country to work with the communities there, living for a whole year without treatment. She credits a vegetarian diet for reducing her symptoms.

Daniella remarked that being at the HAEi Regional Conference EMEA had been great for her, with the chance to question experts about treatment. Armed with new knowledge, she is excited to go back home and work with her doctors.

Daniella expressed a hope that in the future there will be a Member Organization in Mozambique, and is motivated by a memory of spending time in hospital with a young guy who had the same symptoms as her: “He used a handkerchief to hide his face, which was the same thing I had done for years and years because I was ashamed. My biggest dream is to be able to find him and tell him that I have an answer for this disease.” For that reason, Daniella is committed to bringing testing for HAE to Mozambique.

Meryem Jennane – Morocco

She found the HAEi website and sent an email. Someone responded, and her life changed.

Meryem from Morocco recalled her mother suffering several painful and debilitating episodes of illness. She was the only one in her family to suffer. The only name they gave her mystery condition was “periodical illness.”

Meryem herself first experienced symptoms at the end of stressful high school examinations. Her hand swelled, which she thought was all the writing during the tests. But, from that moment, she had what she described as many “crises.”

Meryem recounts how her HAE, which she now knows is HAE type III (HAE with normal C1 inhibitor), is highly sensitive to stress. Her stressful job in finance led to a scary throat attack. Thankfully, Meryem’s parents were staying with her at the time and could get her to hospital. Lying in hospital, Meryem felt frightened. She told herself this cannot continue. She increased her research. Eventually, she found the HAEi website and sent an email. Someone responded, and her life changed.

Meryem was put in touch with the Moroccan organization. Plucking up the courage to join a meeting organized to coincide with the national day of hereditary angioedema, she went along and, for the first time, didn’t feel alone and could get her questions answered. At this point, she says she could take matters into her own hands.

Despite challenges with care and medication in Morocco, Meryem describes doctors who are really careful to help her. She is working with her Member Organization and sees signs of progress. She concluded her speech by telling everyone present: “We don’t lose hope because hope brings life.”

Verche Jovanovska Jankovska – North Macedonia

We all get used to the everyday fights of people with HAE, but to others, they can be an inspiration.

Verche started with a story. A few years back, her then nine-year-old son wanted to run in a 5km race. On the morning of the event, he had an HAE attack, but after treatment, he insisted on still participating. Then, a journalist contacted Verche. To Verche, the story seemed mundane, but the journalist insisted it was very newsworthy. The resulting media coverage turned her son into a hero of the event and helped increase awareness of HAE.

Verche told the story to illustrate how we all get used to the everyday fights of people with HAE, but to others, they can be an inspiration.

Thinking back further, Verche described her diagnosis. Despite a first attack at the age of four, diagnosis took another four years. Her twin sister was hospitalized for weeks with a facial attack. Luckily, a knowledgeable doctor was on hand, and he called every member of our family. In just a few weeks, a diagnosis of HAE was confirmed. At the time, treatment was unknown.

One of the everyday fights Verche mentioned was not to let HAE define her. She said: “We had dreams to lift our single mother from the verge of poverty. I continued my education and got a pharmacy degree. I now work in quality control for the biggest pharmaceutical company in the region. Mine is the final signature that means a drug can go out. Colleagues told her: ‘If you deal with this (HAE), you can deal with everything.”

Verche’s mother remembers that her mother died at 33 years old. She was undiagnosed, but when she died, she was swollen. Speaking more about her family, Verche praised her sister, who helped found the Macedonian HAE Member Organization in 2009, along with physicians and Verche. Since then, she described their success as: “We really moved mountains.”

Verche also praised her husband, who took on the role of caregiver willingly and has gone from being: ‘The person who was afraid of needles to the best medical guy in the family, administering therapy as if it is nothing and then going back to bed.’

Verche and her husband hope their son is the last to have HAE. Diagnosed at just one-year-old, he struggled with very frequent attacks. Expensive medicines were bought, but that wasn’t sustainable. Verche started writing, asking for support. She said, “The only person who ever answered was Henrik Balle Boysen. He brought us to Copenhagen for the first global conference in 2012. We were welcomed with ribbons that said, ‘Together we are strong’. We started to cry; it was the first time we felt we belonged somewhere.”

That started what Verche described as the ‘Macedonian miracle.’ Henrik personally came to help in advocating with officials for treatment. A vast range of public awareness-raising activities were undertaken, from riding bikes to running marathons. Verche recalls being on TV so often she was recognized by a bartender.

Verche told the audience not to wait patiently for someone else to solve your problems: “When you think your life is not good, remember you are one of the 7% that Fiona mentioned earlier. We have treatments and we have options. If you feel stigmatized, remember we all of us felt that way at some point. We have left the dark ages of just 10-15 years ago.”

At the conclusion of these emotional and powerful presentations, all speakers were given a long and warm round of applause from all present.

Debs Corcoran, HAEi’s Chief Scientific Officer and  Nevena Tsutsumanova, Manager, Youngsters’ Community and Special Projects came to the stage to present “One More Thing”, the HAEi LEAP program.

They explained that HAEi LEAP is an educational program that allows young people to learn new skills and develop as individuals and advocates. Ultimately, they told the audience, it paves the way for future leaders. The program was launched in 2023 and was amazingly successful, with 20 young people gathered in Dubai. The feedback has been excellent and has led to many exciting new projects with these young people engaged with their Member Organizations.

Debs and Nevena were delighted to announce that HAEi LEAP would happen again in 2024!

They told the audience that young people aged 16-25 and their Member Organization should get together to discuss what’s involved, what a project might entail, and how best to apply. Some examples of projects being implemented by young people include:

  • A youngsters’ meeting in Poland
  • A youngsters’ community in Australasia
  • A website update in Peru
  • Writing a guide for HAE caregivers in the USA
  • Organizing a healthcare professional meeting in Oman
  • Conducting healthcare professional research in Qatar
  • Organizing a sporting/ walking event to raise awareness in Serbia

Our young people are the future of advocacy and will change the world. We can’t wait to see what they do in HAEi LEAP 2024. Click to read more about LEAP 2024 the HAEi Youngsters’ website.